Document is current
Any future updates will be listed below
-
Authors
Keim-Malpass, Jessica
Ratcliffe, Sarah J.
Clark, Matthew T.
Krahn, Katy N.
Monfredi, Oliver J.
Hamil, Susan
Yousefvand, Gholamreza
Jones, Marieke K.
Nelson, Ashley
Moorman, Liza P.
Moorman, J. Randall
Bourque, Jamieson M.
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04359641 at ClinicalTrials.govDocuments that mention this clinical trial
A randomized controlled trial of artificial intelligence-based analytics for clinical deterioration
https://doi.org/10.1038/s41598-026-39051-z
-
Funding
Funding for this research was provided by:
Agency for Healthcare Research and Quality (R01HS028803)
- License Information
-
More Information
Article History
Received: 1 June 2025
Accepted: 2 February 2026
First Online: 5 February 2026
Declarations
:
: MC is an employee of Nihon Kohden Digital Health Solutions. LPM and JRM are consultants for Nihon Kohden Digital Health Solutions. JKM owns equity shares of ArteraAI and JRM owns equity shares of Medical Predictive Science Corporation, whose products are not discussed in this unrelated work. The other authors decalre no competing interests.
